I think you'll find @preempt knows PEN and it's history very well. Probably even knows that it's not cash flow + as you've ramped on the thread.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025